When torcetrapib clinical trial results were presented to Pfizer chairman Jeff Kindler, he did not equivocate. Despite the financial implications, the trials were stopped immediately.
Tough choice? Yes. But, more importantly, principled choice.
The principle? Patient safety. And, as my father used to say, it’s not a principle unless it hurts to stand by it.
Bravo.
I must have missed the words of congratulations from the IOM, Senator Grassley, and Sidney Wolfe.
Tough choice? Yes. But, more importantly, principled choice.
The principle? Patient safety. And, as my father used to say, it’s not a principle unless it hurts to stand by it.
Bravo.
I must have missed the words of congratulations from the IOM, Senator Grassley, and Sidney Wolfe.
